Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Clinical Studies Sponsored by Alaunos Therapeutics

Clinical Studies where

Trial Sponsor

Name	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
‌ A Phase I Trial of ZIO-101 in Hematologic Cancers	NCT00592046	Lymphoma Multiple myeloma ‌ Acute leukemia	2005	2008	Interventional
‌ HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors	NCT05124743	Endometrial cancer Ovarian cancer Cholangiocarcinoma	September 24, 2021	May 28, 2028	Observational
‌ Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)	NCT01555710		2012	2015	Interventional
‌ Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors	NCT01340547		2011	2013	Interventional
‌ Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer	NCT01113970	Metastatic breast cancer	2010	2013	Interventional
‌ Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies	NCT01242072	Cancer Testicular cancer Osteosarcoma Ovarian cancer ‌ Malignancy Thymoma	2010	2012	Interventional
‌ Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma	NCT01168791		2010	2013	Interventional
‌ Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors	NCT00591383		2008	2013	Interventional
‌ Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans	NCT00591890		2007	2009	Interventional
‌ Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma	NCT01139359	Lymphoma	2010	2011	Interventional
‌ Study of Oral Darinaparsin in Patients With Advanced Solid Tumors	NCT01139346		2010	2012	Interventional
‌ Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma	NCT00815607	Melanoma	2009	2013	Interventional
‌ Study of Oral Palifosfamide Tris in Solid Tumors	NCT00607711		2008	2009	Interventional
‌ Phase I Study in Advanced Solid Tumors	NCT00591292		2007	2013	Interventional
‌ A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma	NCT00423306	Hepatocellular carcinoma	2007	2013	Interventional
‌ Phase I Study of Indibulin in Patients With Solid Tumors	NCT00591136		2003	2008	Interventional
‌ Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers	NCT00421213		2006	2012	Interventional
‌ Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors	NCT00608803		2008	2009	Interventional
‌ Study of ZIO-101 in Multiple Myeloma	NCT00303199	Multiple myeloma	2006	2007	Interventional
‌ A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b	NCT00423644	Multiple myeloma	2007	2013	Interventional
‌ Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors	NCT00726687		2008	2013	Interventional
‌ Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas	NCT00591422		2007	2013	Interventional
‌ A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer	NCT00421135		2006	2007	Interventional
‌ Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas	NCT00592163		2007	2013	Interventional
‌ A Phase I Trial of ZIO-101 in Solid Tumors	NCT00591396		2005	2008	Interventional

Results per page:

33 results

0 selected

33 results

0 selected